Purchases and Sales Made in Q1 2025 in Black Diamond Therapeutics, Inc. (BDTX)
This table provides information about the institutional ownership of Black Diamond Therapeutics, Inc. (BDTX) during Q1 2025. The information is specifically focused on institutions that hold shares of Black Diamond Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2025
Q1 2025
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-67.5K- 0.64% |
$105K - $184K
|
10.4M
$26M
|
|
|
May 15, 2025
Q1 2025
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-71.5K- 49.45% |
$111K - $195K
|
73.1K
$183K
|
|
|
May 15, 2025
Q1 2025
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-81.5K- 76.0% |
$126K - $223K
|
25.7K
$64.4K
|
|
|
May 13, 2025
Q1 2025
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-89K- 13.45% |
$138K - $243K
|
572K
$1.43M
|
|
|
May 15, 2025
Q1 2025
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-109K- 82.97% |
$170K - $299K
|
22.5K
$56.1K
|
|
|
May 14, 2025
Q1 2025
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-309K- 55.29% |
$479K - $844K
|
250K
$625K
|
|
|
May 13, 2025
Q1 2025
|
Kennedy Capital Management, Inc.
St Louis, MO |
SELL
|
- |
-370K- 85.36% |
$574K - $1.01M
|
63.5K
$159K
|
|
|
May 14, 2025
Q1 2025
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-824K- 91.16% |
$1.28M - $2.25M
|
79.9K
$200K
|
|
|
May 14, 2025
Q1 2025
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-5.78M- 67.91% |
$8.97M - $15.8M
|
2.73M
$6.83M
|